Ledger. Australian venture funding, tracked

Company · Healthcare

Genetic Signatures

Develops PCR-based infectious disease tests under its EasyScreen brand

North Ryde, NSW

What Genetic Signatures bought

Companies Genetic Signatures acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company KindAnnounced Price Sources
Genetic Signatures is not recorded as having acquired anything.

Something wrong? Tell us